Heterogeneity of Drug Target Expression Among Metastatic Lesions: Lessons from a Breast Cancer Autopsy Program

Overview

Journal Clin Cancer Res

Specialty Oncology

Date 2008 Jun 19

PMID 18559575

Citations 16

Authors

Patricia S Steeg

Affiliations

Soon will be listed here.

Citing Articles

Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies.

Bacon E, Ihle K, Guo W, Egelston C, Simons D, Wei C NPJ Precis Oncol. 2024; 8(1):81.

PMID: 38553598 PMC: 10980766. DOI: 10.1038/s41698-024-00572-3.

Long-chain fatty acyl coenzyme A inhibits NME1/2 and regulates cancer metastasis.

Zhang S, Nelson O, Price I, Zhu C, Lu X, Fernandez I Proc Natl Acad Sci U S A. 2022; 119(11):e2117013119.

PMID: 35259022 PMC: 8931372. DOI: 10.1073/pnas.2117013119.

NDK/NME proteins: a host-pathogen interface perspective towards therapeutics.

Gupta A, Sinha K, Abdin M, Puri N, Selvapandiyan A Curr Genet. 2021; 68(1):15-25.

PMID: 34480234 DOI: 10.1007/s00294-021-01198-9.

The lingering mysteries of metastatic recurrence in breast cancer.

Riggio A, Varley K, Welm A Br J Cancer. 2020; 124(1):13-26.

PMID: 33239679 PMC: 7782773. DOI: 10.1038/s41416-020-01161-4.

MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis.

Das S, Maji S, Wechman S, Bhoopathi P, Pradhan A, Talukdar S Pharmacol Res. 2020; 155:104695.

PMID: 32061839 PMC: 7551653. DOI: 10.1016/j.phrs.2020.104695.

References

Suzuki M, Tarin D . Gene expression profiling of human lymph node metastases and matched primary breast carcinomas: clinical implications. Mol Oncol. 2009; 1(2):172-80. PMC: 5543892. DOI: 10.1016/j.molonc.2007.03.005. View

Weigelt B, Hu Z, He X, Livasy C, Carey L, Ewend M . Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005; 65(20):9155-8. DOI: 10.1158/0008-5472.CAN-05-2553. View

Eberhard D, Giaccone G, Johnson B . Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. J Clin Oncol. 2008; 26(6):983-94. DOI: 10.1200/JCO.2007.12.9858. View

Kristek J, Dmitrovic B, Kurbel S, Sakic K, Krajinovic Z, Blazicevic V . Tumor growth fraction, expression of estrogen and progesterone receptors, p53, bcl-2 and cathepsin D activity in primary ductal invasive breast carcinoma and their axillary lymph node metastases. Coll Antropol. 2008; 31(4):1043-7. View

van Agthoven T, Timmermans M, Dorssers L, Henzen-Logmans S . Expression of estrogen, progesterone and epidermal growth factor receptors in primary and metastatic breast cancer. Int J Cancer. 1995; 63(6):790-3. DOI: 10.1002/ijc.2910630607. View

Iguchi C, Nio Y, Itakura M . Heterogeneic expression of estrogen receptor between the primary tumor and the corresponding involved lymph nodes in patients with node-positive breast cancer and its implications in patient outcome. J Surg Oncol. 2003; 83(2):85-93. DOI: 10.1002/jso.10243. View

Weigelt B, Wessels L, Bosma A, Glas A, Nuyten D, He Y . No common denominator for breast cancer lymph node metastasis. Br J Cancer. 2005; 93(8):924-32. PMC: 2361648. DOI: 10.1038/sj.bjc.6602794. View

Steeg P, Theodorescu D . Metastasis: a therapeutic target for cancer. Nat Clin Pract Oncol. 2008; 5(4):206-19. PMC: 2709494. DOI: 10.1038/ncponc1066. View

Koda M, Sulkowski S, Kanczuga-Koda L, Surmacz E, Sulkowska M . Expression of ERalpha, ERbeta and Ki-67 in primary tumors and lymph node metastases in breast cancer. Oncol Rep. 2004; 11(4):753-9. View

10.

Hao X, Sun B, Hu L, Lahdesmaki H, Dunmire V, Feng Y . Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer. 2004; 100(6):1110-22. DOI: 10.1002/cncr.20095. View

11.

Weigelt B, Glas A, Wessels L, Witteveen A, Peterse J, Vant Veer L . Gene expression profiles of primary breast tumors maintained in distant metastases. Proc Natl Acad Sci U S A. 2003; 100(26):15901-5. PMC: 307665. DOI: 10.1073/pnas.2634067100. View

12.

Vecchi M, Confalonieri S, Nuciforo P, Vigano M, Capra M, Bianchi M . Breast cancer metastases are molecularly distinct from their primary tumors. Oncogene. 2007; 27(15):2148-58. DOI: 10.1038/sj.onc.1210858. View

13.

Harvey J, Clark G, Osborne C, Allred D . Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol. 1999; 17(5):1474-81. DOI: 10.1200/JCO.1999.17.5.1474. View

14.

Dikicioglu E, Barutca S, Meydan N, Meteoglu I . Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes. Int J Clin Pract. 2005; 59(9):1039-44. DOI: 10.1111/j.1742-1241.2005.00546.x. View

15.

Dowsett M, Allred C, Knox J, Quinn E, Salter J, Wale C . Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial. J Clin Oncol. 2008; 26(7):1059-65. DOI: 10.1200/JCO.2007.12.9437. View

16.

Tacca O, Penault-Llorca F, Abrial C, Mouret-Reynier M, Raoelfils I, Durando X . Changes in and prognostic value of hormone receptor status in a series of operable breast cancer patients treated with neoadjuvant chemotherapy. Oncologist. 2007; 12(6):636-43. DOI: 10.1634/theoncologist.12-6-636. View

17.

Wu J, Fackler M, Halushka M, Molavi D, Taylor M, Teo W . Heterogeneity of breast cancer metastases: comparison of therapeutic target expression and promoter methylation between primary tumors and their multifocal metastases. Clin Cancer Res. 2008; 14(7):1938-46. PMC: 2965068. DOI: 10.1158/1078-0432.CCR-07-4082. View

18.

Feng Y, Sun B, Li X, Zhang L, Niu Y, Xiao C . Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients. Breast Cancer Res Treat. 2006; 103(3):319-29. DOI: 10.1007/s10549-006-9385-7. View

19.

Dupont V, Gentien D, Oberkampf M, De Rycke Y, Blin N . A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients. Int J Cancer. 2007; 121(5):1036-46. DOI: 10.1002/ijc.22775. View

20.

Ding L, Sunamura M, Kodama T, Yamauchi J, Duda D, Shimamura H . In vivo evaluation of the early events associated with liver metastasis of circulating cancer cells. Br J Cancer. 2001; 85(3):431-8. PMC: 2364062. DOI: 10.1054/bjoc.2001.1911. View